Zimmer Biomet

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Zimmer Biomet and other ETFs, options, and stocks.

About ZBH

Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products.

CEO

Ivan Tornos

CEOIvan Tornos

Employees

17,000

Employees17,000

Headquarters

Warsaw, Indiana

HeadquartersWarsaw, Indiana

Founded

1927

Founded1927

Employees

17,000

Employees17,000

ZBH Key Statistics

Market cap

17.63B

Market cap17.63B

Price-Earnings ratio

23.02

Price-Earnings ratio23.02

Dividend yield

1.01%

Dividend yield1.01%

Average volume

1.58M

Average volume1.58M

High today

$95.06

High today$95.06

Low today

$91.45

Low today$91.45

Open price

$93.83

Open price$93.83

Volume

1.37M

Volume1.37M

52 Week high

$106.88

52 Week high$106.88

52 Week low

$79.12

52 Week low$79.12

Stock Snapshot

The current Zimmer Biomet(ZBH) stock price is $92.44, with a market capitalization of 17.63B. The stock trades at a price-to-earnings (P/E) ratio of 23.02 and offers a dividend yield of 1.01%.

On 2026-09-11, Zimmer Biomet(ZBH) stock moved within a range of $91.45 to $95.06. With shares now at $92.44, the stock is trading +1.1% above its intraday low and -2.8% below the session's peak.

Trading volume for Zimmer Biomet(ZBH) stock has reached 1.37M, versus its average volume of 1.58M.

The stock's 52-week range extends from a low of $79.12 to a high of $106.88.

ZBH News

Simply Wall St 1d

Zimmer Biomet Overhauls Leadership Team As Commercial Transformation Takes Shape - simplywall.st

...

TipRanks 3d

Zimmer Biomet Restructures Leadership to Boost U.S. Growth

The latest update is out from Zimmer Biomet Holdings ( (ZBH) ). On September 8, 2026, Zimmer Biomet announced a restructuring of its Americas and Global Busine...

Seeking Alpha 3d

Stryker drops after comments on vascular and ortho segments

Stryker Corporation (SYK) hit a new 52-week low, sending shares of its rival Zimmer Biomet (ZBH) lower after discussing headwinds in its vascular and orthopedic...

Analyst ratings

69%

of 29 ratings

Buy

27.6%

Hold

69%

Sell

3.4%

More ZBH News

TipRanks 7d

Zimmer Biomet’s Vivacit-E Hip Liner Study Wrap-Up: What Investors Should Know

Zimmer Biomet Holdings (ZBH) announced an update on their ongoing clinical study. The Vivacit-E Post-market Follow-up Study, officially titled “Post Market Cli...

People also own

Based on the portfolios of people who own ZBH. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.